Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 39876 - 39900 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Etoposide	Approved Investigational	ZNF45	7596	downregulated	Etoposide results in decreased expression of ZNF45 mRNA	19q13.2	A21499
Etoposide	Approved Investigational	ZNF544	27300	downregulated	Etoposide results in decreased expression of ZNF544 mRNA	19q13.43	A21499
Etoricoxib	Approved Investigational Withdrawn	ICAM1	3383	downregulated	etoricoxib results in decreased expression of ICAM1 mRNA	19p13.2	A22156
Eugenol	Approved Investigational	ABCA6	23460	downregulated	Eugenol results in decreased expression of ABCA6 mRNA	17q24.2-q24.3	A22388
Eugenol	Approved Investigational	AHRR	57491	upregulated	Eugenol results in increased expression of AHRR mRNA	5p15.33	A22598
Eugenol	Approved Investigational	AKR1B1	231	upregulated	Eugenol results in increased expression of AKR1B1 mRNA	7q33	A21074
Eugenol	Approved Investigational	AKR1B10	57016	upregulated	Eugenol results in increased expression of AKR1B10 mRNA	7q33	A21074 A20662
Eugenol	Approved Investigational	AKR1C1	1645	upregulated	Eugenol results in increased expression of AKR1C1 mRNA	10p15.1	A21074
Eugenol	Approved Investigational	AKR1C2	1646	upregulated	Eugenol results in increased expression of AKR1C2 mRNA	10p15.1	A20662
Eugenol	Approved Investigational	AKR1C3	8644	upregulated	Eugenol results in increased expression of AKR1C3 mRNA	10p15.1	A21074
Eugenol	Approved Investigational	ALPL	249	upregulated	Eugenol results in increased expression of ALPL mRNA	1p36.12	A21618
Eugenol	Approved Investigational	ARHGAP17	55114	downregulated	Eugenol results in decreased expression of ARHGAP17 mRNA	16p12.1	A22388
Eugenol	Approved Investigational	ARL4C	10123	upregulated	Eugenol results in increased expression of ARL4C mRNA	2q37.1	A22388
Eugenol	Approved Investigational	ATF3	467	upregulated	Eugenol results in increased expression of ATF3 mRNA	1q32.3	A21534
Eugenol	Approved Investigational	B2M	567	upregulated	Eugenol results in increased expression of B2M mRNA	15q21.1	A22599
Eugenol	Approved Investigational	BCL2	596	downregulated	Eugenol results in decreased expression of BCL2 mRNA	18q21.33	A22600
Eugenol	Approved Investigational	BCLAF1	9774	downregulated	Eugenol results in decreased expression of BCLAF1 mRNA	6q23.3	A22388
Eugenol	Approved Investigational	BMP6	654	upregulated	Eugenol results in increased expression of BMP6 mRNA	6p24.3	A22388
Eugenol	Approved Investigational	BUB1	699	downregulated	Eugenol results in decreased expression of BUB1 mRNA	2q13	A22388
Eugenol	Approved Investigational	CALCRL	10203	upregulated	Eugenol results in increased expression of CALCRL mRNA	2q32.1	A22388
Eugenol	Approved Investigational	CAT	847	upregulated	Eugenol results in increased expression of CAT mRNA	11p13	A21074
Eugenol	Approved Investigational	CCL13	6357	upregulated	Eugenol results in increased expression of CCL13 mRNA	17q12	A22599
Eugenol	Approved Investigational	CCL19	6363	upregulated	Eugenol results in increased expression of CCL19 mRNA	9p13.3	A22599
Eugenol	Approved Investigational	CCL2	6347	downregulated	Eugenol results in decreased expression of CCL2 mRNA	17q12	A22388 A22599
Eugenol	Approved Investigational	CCL2	6347	upregulated	Eugenol results in increased expression of CCL2 mRNA	17q12	A22392

Displaying entries 39876 - 39900 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability